Norovirus infections
Clinical trials for Norovirus infections explained in plain language.
Never miss a new study
Get alerted when new Norovirus infections trials appear
Sign up with your email to follow new studies for Norovirus infections, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a pill stop the stomach bug? new oral norovirus vaccine put to the test
Vaccine CompletedThis early-stage trial is testing whether a new oral vaccine can safely protect against norovirus, the highly contagious virus that causes vomiting and diarrhea. Healthy adults aged 18 to 80 will receive a single dose of the vaccine, which targets two common norovirus strains. Re…
Matched conditions: NOROVIRUS INFECTIONS
Phase 1 • Sponsor: Vaxart • Aim: Vaccine
Last updated Jul 29, 2026 00:00 UTC
-
Could a pill protect babies from stomach bugs? new vaccine trial in moms
Vaccine CompletedThis early-stage trial tested an oral norovirus vaccine in 76 healthy breastfeeding mothers to see if it is safe and can trigger immune responses in both mom and her breastmilk. The vaccine is taken as a tablet and targets two common norovirus strains. Researchers hope that antib…
Matched conditions: NOROVIRUS INFECTIONS
Phase 1 • Sponsor: Vaxart • Aim: Vaccine
Last updated Jun 27, 2026 12:07 UTC
-
Stomach flu vaccine shows promise in massive Kids' trial
Vaccine CompletedThis large phase 3 trial tested a new norovirus vaccine in 8,000 healthy children aged 6 months to 13 years. The vaccine targets two common norovirus strains (GⅠ.1 and GⅡ.4) that cause severe vomiting and diarrhea. Researchers compared vaccinated kids to those who got a placebo t…
Matched conditions: NOROVIRUS INFECTIONS
Phase 3 • Sponsor: National Vaccine and Serum Institute, China • Aim: Vaccine
Last updated Jun 27, 2026 08:11 UTC
-
Could a pill stop the stomach bug? new vaccine trial shows promise
Vaccine CompletedThis study tested an experimental oral vaccine designed to protect against norovirus, a highly contagious virus that causes vomiting and diarrhea. Healthy adults aged 18 to 49 received either a single dose of the vaccine or a placebo. About a month later, all volunteers were inte…
Matched conditions: NOROVIRUS INFECTIONS
Phase 1/2 • Sponsor: Vaxart • Aim: Vaccine
Last updated Jun 27, 2026 07:56 UTC